Investigation of eosinophil activating factor in bronchoalveolar lavage fluid of acute eosinophilic pneumonia

Investigation of eosinophil activating factor in bronchoalveolar lavage fluid of acute eosinophilic pneumonia - Investigation of eosinophil activating factor in bronchoalveolar lavage fluid of acute eosinophilic pneumonia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020887

Enrollment

Registered

2016-04-02

Start date

2015-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute eosinophilic pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute eosinophilic pneumonia, patients with chronic eosinophilic pneumonia and patients with sarcoidosis

Exclusion criteria

Exclusion criteria: Patients who have been treated by systemic corticosteroid

Design outcomes

Primary

Measure	Time frame
Expression of periostin in serum, bronchoalveolar lavage fluid or lung tissue	—

Secondary

Measure	Time frame
Percentage of innate lymphoid cells in bronchoalveolar lavage fluid	—

Countries

Japan

Contacts

Public ContactKazuyuki Nakagome

Saitama Medical University Department of Respiratory Medicine

nakagome@saitama-med.ac.jp049-276-1319

Outcome results